Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles
- 1 March 2004
- journal article
- Published by Elsevier in The Lancet
- Vol. 363 (9411) , 775-781
- https://doi.org/10.1016/s0140-6736(04)15693-6
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Smoking Research Foundation
- Vehicle Racing Commemorative Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 19 references indexed in Scilit:
- Fluorescent labelling of cRNA for microarray applicationsNucleic Acids Research, 2003
- Small Cell Lung Cancer*Chest, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Identification of FOXC1 as a TGF-β1 Responsive Gene and Its Involvement in Negative Regulation of Cell GrowthGenomics, 2002
- Integrated classification of lung tumors and cell lines by expression profilingProceedings of the National Academy of Sciences, 2002
- Morphometry Confirms the Presence of Considerable Nuclear Size Overlap Between “Small Cells” and “Large Cells” in High-Grade Pulmonary Neuroendocrine NeoplasmsAmerican Journal of Clinical Pathology, 2001
- Neurexins: Three genes and 1001 productsTrends in Genetics, 1998
- Monoclonal Antibody to Thyroid Transcription Factor-1: Production, Characterization, and Usefulness in Tumor DiagnosisHybridoma, 1996
- Amplified RNA synthesized from limited quantities of heterogeneous cDNA.Proceedings of the National Academy of Sciences, 1990